MedPath
NMPA Approval

Rivastigmine Bitartrate Oral Solution

国药准字H20249583

December 1, 2024

Drug Information

重酒石酸利斯的明口服溶液

口服溶液剂

50ml:0.1g(按C₁₄H₂₂N₂O₂计)

化学药品

December 1, 2024

Company Information

Applicant Company

浙江省湖州市王母山路1800号2号楼4层南402室-2

Manufacturing Company

浙江省湖州市德清县阜溪街道英溪北路689号

© Copyright 2025. All Rights Reserved by MedPath